Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Dec;107(4):1008–1012. doi: 10.1111/j.1476-5381.1992.tb13399.x

Analysis of the agonist activity of fenoldopam (SKF 82526) at the vascular 5-HT2 receptor.

M I Christie 1, D Harper 1, G W Smith 1
PMCID: PMC1907922  PMID: 1361397

Abstract

1. The 5-HT2 receptor agonist activity of fenoldopam (SKF 82526) was characterized in the rabbit isolated aorta preparation. 2. Fenoldopam was an agonist at the vascular 5-HT2 receptor with lower affinity and efficacy than the naturally occurring agonist 5-hydroxytryptamine (5-HT). Fenoldopam had an affinity (pKA) of 5.84 +/- 0.04 and efficacy (tau) of 0.57 +/- 0.04, whereas 5-HT had a pKA of 6.65 +/- 0.12 and tau of 2.66 +/- 0.41. 3. The constrictor effects of fenoldopam and 5-HT were competitively antagonized by the 5-HT2 antagonist, ketanserin, with pKB values of 8.81 +/- 0.11 and 8.83 +/- 0.10 respectively. 4. Prior incubation with fenoldopam produced a concentration-related rightward shift of a subsequent 5-HT concentration-response curve. This inhibition was specific for 5-HT since constrictor responses to angiotensin II were unaffected. 5. This study indicates that the D1 receptor agonist, fenoldopam, acts as an agonist at the vascular 5-HT2 receptor, but with an affinity and efficacy less than that of the naturally occurring agonist, 5-HT.

Full text

PDF
1008

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlow R. B., Scott N. C., Stephenson R. P. The affinity and efficacy of onium salts on the frog rectus abdominis. Br J Pharmacol Chemother. 1967 Sep;31(1):188–196. doi: 10.1111/j.1476-5381.1967.tb01989.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ben-Harari R. R., Dalton B. A., Osman R., Maayani S. Kinetic characterization of 5-hydroxytryptamine receptor desensitization in isolated guinea-pig trachea and rabbit aorta. J Pharmacol Exp Ther. 1991 Apr;257(1):416–424. [PubMed] [Google Scholar]
  3. Black J. W., Leff P., Shankley N. P., Wood J. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol. 1985 Feb;84(2):561–571. doi: 10.1111/j.1476-5381.1985.tb12941.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983 Oct 13;305(5935):627–630. doi: 10.1038/305627a0. [DOI] [PubMed] [Google Scholar]
  5. De Meyer G. R., Bult H., Martin J. F., Van Hoydonck A. E., Herman A. G. The effect of a developing neo-intima on serotonergic and adrenergic contractions. Eur J Pharmacol. 1990 Oct 23;187(3):519–524. doi: 10.1016/0014-2999(90)90380-o. [DOI] [PubMed] [Google Scholar]
  6. Gretler D. D., Jones K. C., Murphy M. B. 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle. J Pharmacol Exp Ther. 1992 Feb;260(2):491–498. [PubMed] [Google Scholar]
  7. Hahn R. A., Wardell J. R., Jr, Sarau H. M., Ridley P. T. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. J Pharmacol Exp Ther. 1982 Nov;223(2):305–313. [PubMed] [Google Scholar]
  8. Le Monnier de Gouville A. C., Lawson K., Thiry C., Cavero I. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. J Pharmacol Exp Ther. 1991 Mar;256(3):1049–1056. [PubMed] [Google Scholar]
  9. Leff P., Martin G. R. Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists? Br J Pharmacol. 1986 Jul;88(3):585–593. doi: 10.1111/j.1476-5381.1986.tb10239.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Leff P., Prentice D. J., Giles H., Martin G. R., Wood J. Estimation of agonist affinity and efficacy by direct, operational model-fitting. J Pharmacol Methods. 1990 May;23(3):225–237. doi: 10.1016/0160-5402(90)90066-t. [DOI] [PubMed] [Google Scholar]
  11. Ohlstein E. H., Berkowitz B. A. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors. Eur J Pharmacol. 1985 Jan 22;108(2):205–208. doi: 10.1016/0014-2999(85)90728-9. [DOI] [PubMed] [Google Scholar]
  12. Ohlstein E. H., Zabko-Potapovich B., Berkowitz B. A. The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist. Eur J Pharmacol. 1985 Dec 3;118(3):321–329. doi: 10.1016/0014-2999(85)90143-8. [DOI] [PubMed] [Google Scholar]
  13. Sobey C. G., Dusting G. J., Woodman O. L. Enhanced vasoconstriction by serotonin in rabbit carotid arteries with atheroma-like lesions in vivo. Clin Exp Pharmacol Physiol. 1991 May;18(5):367–370. doi: 10.1111/j.1440-1681.1991.tb01465.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES